# ATRenew Inc.: financial statements, quarterly

RERE · NYSE · CIK 1838957 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rere.md) · [Financials](/companies/rere/financials.md) · [Filings](/companies/rere/filings.md) · [Insiders](/companies/rere/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rere/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [213](/filings/0001564590-22-016124.md) | [247](/filings/0000950170-23-013162.md) | [279](/filings/0000950170-24-043854.md) | [270](/filings/0000950170-25-053014.md) | [220](/filings/0001193125-26-146260.md) |
| Current assets | $m | not reported | [651](/filings/0001564590-22-016124.md) | [564](/filings/0000950170-23-013162.md) | [638](/filings/0000950170-24-043854.md) | [571](/filings/0000950170-25-053014.md) | [678](/filings/0001193125-26-146260.md) |
| Total assets | $m | not reported | [1,177](/filings/0001564590-22-016124.md) | [732](/filings/0000950170-23-013162.md) | [774](/filings/0000950170-24-043854.md) | [697](/filings/0000950170-25-053014.md) | [853](/filings/0001193125-26-146260.md) |
| Current liabilities | $m | not reported | [129](/filings/0001564590-22-016124.md) | [148](/filings/0000950170-23-013162.md) | [238](/filings/0000950170-24-043854.md) | [179](/filings/0000950170-25-053014.md) | [272](/filings/0001193125-26-146260.md) |
| Total liabilities | $m | not reported | [170](/filings/0001564590-22-016124.md) | [169](/filings/0000950170-23-013162.md) | [251](/filings/0000950170-24-043854.md) | [191](/filings/0000950170-25-053014.md) | [282](/filings/0001193125-26-146260.md) |
| Long-term debt | $m | [32.6](/filings/0001564590-22-016124.md) | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | [14.9](/filings/0001564590-22-016124.md) | [18.0](/filings/0000950170-23-013162.md) | [49.3](/filings/0000950170-24-043854.md) | [30.8](/filings/0000950170-25-053014.md) | [46.2](/filings/0001193125-26-146260.md) |
| Shareholders' equity | $m | not reported | [1,008](/filings/0001564590-22-016124.md) | [563](/filings/0000950170-23-013162.md) | [523](/filings/0000950170-24-043854.md) | [506](/filings/0000950170-25-053014.md) | [571](/filings/0001193125-26-146260.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.